Inactive Instrument

Highlights UMN Pharma Inc.

Equities

4585

JP3944320005

Highlights

Unlock all the news: Be the first to know and act before the market!

AIM ImmunoTech Inc. Enters into Mutual Confidentiality Agreement with UMN Pharma Inc., Japan National Institute of Infectious Diseases, and Shionogi & Co., Ltd	27/04/20	CI
Shionogi & Co., Ltd. completed the acquisition of 52.74% stake in UMN Pharma Inc. for ¥5 billion.	11/12/19	CI
Shionogi & Co., Ltd. made a tender offer to acquire 69.6% stake in UMN Pharma Inc for approximately ¥6.7 billion.	29/10/19	CI
UMN Pharma Inc. Reports Non-Consolidated Earnings Results for the Six Months Ended June 30, 2019; Provides Earnings Guidance for the Fiscal Year Ending December 31, 2019	30/07/19	CI
UMN Pharma Inc. Reports Non-Consolidated Earnings Results for the Quarter Ended March 31, 2018; Provides Earnings Guidance for the Fiscal Year Ending December 31, 2018	26/04/18	CI
UMN Pharma Inc. Announces Non Consolidated Earnings Results for the Year Ended December 31, 2017; Provides Earnings Guidance for the Full Year of 2018	13/02/18	CI
Umn Pharma Inc. Announces Non-Consolidated Earnings Results for the Nine Months Ended September 30, 2017; Provides Earnings Guidance for the Fiscal Year Ending December. 31, 2017	30/10/17	CI
UMN Pharma Inc. Announces Nonconsolidated Earnings Results for the Six Months Ended June 30, 2017; Provides Nonconsolidated Earnings Guidance for the Year Ending December 31, 2017	30/07/17	CI
Umn Pharma Inc. Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2017; Provide Earnings Guidance for the Year 2017	27/04/17	CI
UMN Pharma Inc. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended December 31, 2016; Provides Earnings Guidance for the Year Ending December 31, 2017	13/02/17	CI
API Co., Ltd. acquired 50% stake in Unigen KK from UMN Pharma Inc..	31/01/17	CI
Umn Pharma Inc. Announces Consolidated Earnings Results for the First Nine Months Ended September 30, 2016; Provides Earnings Guidance for the Year Ending March 31, 2016	30/10/16	CI
UMN Pharma Inc. Announces Consolidated Earnings Results for the Six Months Ended June 30, 2016; Provides Earnings Guidance for the Year Ending December 31, 2016	28/07/16	CI
UMN Pharma Inc. Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2016	27/04/16	CI
UMN Pharma Inc. Announces Consolidated and Non-Consolidated Earnings Results for the Year Ended December 31, 2015	11/02/16	CI
UMN Pharma Inc. Announces Consolidated Earnings Results for the First Nine Month Ended September 30, 2015; Updates Consolidated Earnings Guidance for the Year Ending March 31, 2016	29/10/15	CI
UMN Pharma Inc. Announces Consolidated Earnings Results for the Six Months Ended June 30, 2015; Revises Earnings Guidance for the Year Ending December 31, 2015	30/07/15	CI
UMN Pharma Inc. Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Full Year Ending December 31, 2015	29/04/15	CI
UMN Pharma Inc. Announces Consolidated and Non-Consolidated Earnings Results for the Year Ended December 31, 2014; Provides Earnings Guidance for the Full Year Ending December 31, 2015	12/02/15	CI
Protein Sciences Corporation, UMN Pharma Inc. and IHI Corporation Enter into Agreement to Evaluate Sourcing Flublok® from Japan	22/12/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights UMN Pharma Inc.

Equities

4585

JP3944320005

Highlights

Filters